LINC01138 and hepatocellular carcinoma: LINC01138 induces malignancies via activating arginine methyltransferase 5 and interacting with PRMT5 to promote SREBP1-mediated lipid desaturation individually in hepatocellular carcinoma [26] and clear cell renal cell carcinoma [27].